News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Aastrom Biosciences, Inc. (ASTM) Says FDA Lifts Clinical Hold from Heart Study



6/18/2009 7:24:59 AM

Bookmark and Share

Reuters -- Aastrom Biosciences Inc said U.S. health regulators removed the clinical hold from the company's mid-stage trial of a treatment for congestive heart failure, sending its shares up 39 percent in premarket trade.


Read at Reuters
Read at Wall Street Journal
Read at RTT News
Read at Market Watch


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES